切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2017, Vol. 10 ›› Issue (02) : 223 -225. doi: 10.3877/cma.j.issn.1674-6902.2017.02.029

所属专题: 文献

综述

鲍曼不动杆菌耐药与生物膜形成关系的研究进展
黄冬梅1, 李福祥2,()   
  1. 1. 646000 泸州,西南医科大学
    2. 610083 成都,成都军区总医院重症医学科
  • 收稿日期:2016-11-23 出版日期:2017-04-20
  • 通信作者: 李福祥

Research progress of the relationship between biofilm formation and drug resistance of Acinetobacter baumannii

Dongmei Huang1, Fuxiang Li2()   

  • Received:2016-11-23 Published:2017-04-20
  • Corresponding author: Fuxiang Li
引用本文:

黄冬梅, 李福祥. 鲍曼不动杆菌耐药与生物膜形成关系的研究进展[J]. 中华肺部疾病杂志(电子版), 2017, 10(02): 223-225.

Dongmei Huang, Fuxiang Li. Research progress of the relationship between biofilm formation and drug resistance of Acinetobacter baumannii[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2017, 10(02): 223-225.

1
Karlowsky JA, Draghi DC, Jones ME, et al. Surveillance for antimicrobial susceptibility among clinicalisolates of pseudomonasaeruginosa and Acinetobacter baumannii from hospitalized patients in The United States, 1998 to 2001[J]. Antimicrob Agents Chemother, 2003, 47(5): 1681-1688.
2
Joly Guillou ML. Clinical impact and pathogenicity of Acinetobacter[J]. Clin Microbiol Infect, 2005, 11(11): 868-873.
3
Song JY, Cheong HJ, Noh JY, et al. In vitro Comparison of Anti-Biofilm Effects against Carbapenem-Resistant Acinetobacter baumannii: Imipenem, Colistin, Tigecycline, Rifampicin and Combinations[J]. Infect Chemother, 2015, 47(1): 27-32.
4
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21(3): 538-582.
5
Rodriguez BJ, Marti S, Soto S, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications[J]. Clin Microbiol Infect, 2008, 14(3): 276-278.
6
Jawad A, Seifert H, Snelling AM, et al. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates[J]. J Clin Microbiol, 1998, 36(7): 1938-1941.
7
Wendt C, Dietze B, Dietz E, et al. Survival of Acinetobacter baumannii on dry surfaces[J]. J Clin Microbiol, 1997, 35(6): 1394-1397.
8
Tomaras AP, Dorsey CW, Edelmann RE, et al. Atachment to and biofilm formation on abiotic surfaces by Acinetobacter baumanni: involvement of a novel chaperone-usher pili asembly system[J]. Microbiology, 2003, 149(Pt 12): 3473-3484.
9
Choi CH, Lee JS, Lee YC, et al. Acinetobacter banmannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells[J]. BMC Microbiol, 2008, 8: 216.
10
Cerqueira GM, Peleg AY. Insights into Acinetobacter banmannii pathogenicity[J]. IUBMB Life, 2011, 63(12): 1055-1060.
11
陈铁柱,李晓声,曾文魁,等. 细菌生物膜耐药机制的研究与进展[J]. 中国组织工程研究与临床康复,2010, 14(12): 2205-2208.
12
Badave GK, Kulkarni D. Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge[J]. J Clin Diagn Res, 2015, 9(1): DC08-10.
13
Rao RS, Karthika RU, Singh SP, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii[J]. Indian J Med Microbiol, 2008, 26(4): 333-337.
14
黄妙毅,刘安. 鲍曼不动杆菌生物膜形成能力与耐药性相关性研究[J]. 陕西医学杂志,2015, 44(10): 1373-1374.
15
王政,刘丁,黄冬梅,等. 鲍曼不动杆菌临床分离株生物被膜形成能力与耐药性的研究[J]. 中国病原生物学杂志,2010, 5(6): 405-407.
16
Feng SH, Stojadinovic A, Izadjoo M, et al. Distinctive stages and strain variations of A. baumannii biofilm development under shear flow[J]. J Wound Care, 2013, 22(4): 173-174, 176-178, 180-181.
17
Tresse O, Jouenne T, Junter GA. The role of oxygen limitation in the resistance of agar-entrapped,sessile-like Escherichia coli to aminoglycoside and R-lactam antibiotics[J]. J.Antimicrob.Chemother, 1995, 36(3): 521-526.
18
Wei X, Shen D, Luo Y, et al. Molecular Mechanism of Biofilm Formation in Acinetobacter baumannii[J]. Chin J Nosocomiology, 2010, 18(21): 2735-2738.
19
Niu C, Clemmer KM, Bonomo RA, et al. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii[J]. J Bacteriol, 2008, 190(9): 3386-3392.
20
Gopal R, Kim YG, Lee JH, et al. Synergistic Effects and Antibio lm Properties of Chimeric Peptides against Multidrug-Resistant Acinetobacter baumannii Strains[J]. Antimicrob Agents Chemother, 2014, 58(3): 1622-1629.
21
Azizi O, ShakibaieMR, Modarresi F, et al. Molecular detection of class-D OXA carbapenemase genes in biofilm and non-biofilm forming clinical isolates of Acinetobacter baumannii[J]. Jundishapur J Microbiol, 2015, 8(1): e21042.
22
Nahar A, Anwar S, Ruhul M. Association of biofilm formation with antimicrobial resistance among the acinetobacter species in a tertiary care hospital in Bangladesh[J]. J Med, 2013, 14: 28-32.
23
Espinal P, Marti S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumanniion dry surfaces[J]. J Hosp Infect, 2012, 80(1): 56-60.
24
金晓谦. 呼吸内科分离鲍曼不动杆菌生物膜的形成能力检测及耐药性分析[J]. 中国卫生检疫杂志,2015, 25(13): 2230-2232.
25
刘原,柯蕊,杨妮,等. 呼吸道分离鲍曼不动杆菌生物被膜形成能力与耐药性关系的研究[J]. 中国实验诊断学,2015, 19(8): 1243-1246.
[1] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[2] 张利, 张阳, 马菁菁, 喻哲昊, 葛亮, 孙林春. 细胞壁锚定蛋白SasX调控RNAⅢ参与金黄色葡萄球菌ST239克隆生物膜形成及致病性相关研究[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 252-259.
[3] 孙国先, 蔡萍, 刘微丽, 孟丽君, 侯红玲. 宏基因组二代测序在鲍曼不动杆菌肺炎混合感染者诊疗中的应用[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(02): 115-121.
[4] 蔺飞, 袁明勇, 凌保东. 鲍曼不动杆菌生物膜相关基因研究[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(02): 129-132.
[5] 罗凤华, 魏剑林. 鲍曼不动杆菌生物被膜形成能力与被膜相关基因及耐药性的关系[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(01): 67-71.
[6] 吕慧, 周瑗, 赵奇, 田锐, 王瑞兰. 致死性社区获得性鲍曼不动杆菌肺炎一例报告[J]. 中华肺部疾病杂志(电子版), 2022, 15(04): 609-611.
[7] 金刚, 周倩倩, 王文昊, 刘佳伟, 高军龙, 朱自江. 替加环素治疗老年泛耐药鲍曼不动杆菌肺部术后感染的临床分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(04): 469-471.
[8] 吴水淼, 姚肖依, 李复红, 金发光, 房延凤. 泛耐药鲍曼不动杆菌肺炎的药物治疗临床分析[J]. 中华肺部疾病杂志(电子版), 2021, 14(03): 377-379.
[9] 张童童, 陈伟, 于溯洋, 赵士彭. 结直肠癌PD-1/PD-L1阻断治疗的耐药研究现状[J]. 中华结直肠疾病电子杂志, 2021, 10(02): 205-210.
[10] 刘永海, 祁航, 周婷, 张巍. 社区获得性鲍曼不动杆菌肺炎一例并文献回顾[J]. 中华重症医学电子杂志, 2022, 08(03): 276-280.
[11] 季晓军, 翟晓东, 栗晓芳, 赵佩林, 岳森卉, 张月明. 双途径替加环素治疗广泛耐药鲍曼不动杆菌颅内感染的疗效观察[J]. 中华脑科疾病与康复杂志(电子版), 2022, 12(02): 85-89.
[12] 董行, 郎东浩, 符雪, 李芳, 王凌峰. 群体感应系统与生物膜耐药机制的研究现状[J]. 中华临床医师杂志(电子版), 2021, 15(01): 57-60.
[13] 孙丹, 姬会春, 祝宇翀, 单宇, 刘军权, 廖雨琴. 三叶青提取物TH-w3对金黄色葡萄球菌生物膜的抑制和清除作用[J]. 中华临床实验室管理电子杂志, 2022, 10(04): 227-232.
[14] 李倩珺, 黄淑洪, 雷毅怡, 冯泳琳. 黄连对生物膜状态下耐氟康唑白色念珠菌凝集素样序列基因表达影响[J]. 中华临床实验室管理电子杂志, 2022, 10(02): 89-94.
[15] 杨锐富, 周燕斌. 主要协同转运蛋白超家族膜转运蛋白与细菌生物膜形成的相关性研究进展[J]. 中华诊断学电子杂志, 2023, 11(02): 77-81.
阅读次数
全文


摘要